Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy

This study has been completed.
HealthCore, Inc.
Information provided by (Responsible Party):
Pamlab, Inc. ( Pamlab, L.L.C. ) Identifier:
First received: November 17, 2010
Last updated: July 23, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)